There are several treatment options for prostate hyperplasia (BPH). Medication is an option for patients with milder symptoms. Medication is effective for some patients, but it starts to work in remission, often fails to achieve treatment in patients with severe obstruction, and in the case of long-term treatment, the cost of medication may be higher than the cost of surgical treatment. The surgical procedure to cut open the abdomen and remove the hyperplastic adenoma is thorough and almost never recurs after surgery, but it is traumatic to the body and may also cause many complications, and is becoming less and less common, being used only in the absence of minimally invasive equipment and techniques for grassroots level. Transurethral resection of the prostate (TURP) is currently the most commonly used surgical procedure for prostate enlargement.TURP is characterized by the insertion of an endoscope through the urethra and the removal of the enlarged adenoma in small pieces of a few millimeters using an electrosurgical knife. Compared with open surgery, it reduces the trauma to the body and requires only 3 to 7 days of hospitalization. However, there may be more bleeding during the electrosurgery and the hyperplastic adenoma cannot be completely removed. There is a greater possibility of recurrence of prostatic hyperplasia after the surgery and it is often necessary to operate again. In recent years laser has become a new trend in the treatment of prostatic hyperplasia, with the advantages of less bleeding and faster recovery. The laser prostate surgery can be divided into three types of vaporization, excision and enucleation, of which vaporization and excision are similar in principle to electrodesection, making it difficult to completely remove the hyperplastic tissue and having a high recurrence rate after surgery. The most advanced treatment method is Holmium Laser Enucleation of the Prostate (HoLEP), the principle of which is completely different from electrodesection. The laser is inserted through the endoscope via the urethra up to the affected area, and using the fiber optic conduction laser, the gap between the enlarged prostate gland and the surgical envelope is incised and bluntly separated, and the enlarged adenoma is removed intact from the envelope, and then the adenoma tissue is cut into pieces and sucked out of the body with a tissue crusher. The holmium laser’s aspiration of water begins with the use of a holmium laser, which is used to remove the water from the gland. We can remove the urinary catheter in 1-2 days and urinate smoothly on our own. HoLEP (Holmium Laser Prostate Enucleation) has the following therapeutic advantages: 1. Fine anatomical surgery. HoLEP treatment uses endoscopy to perform surgery without the use of a scalpel to cut open the abdomen, which causes minimal trauma to the patient’s body and can effectively improve the patient’s quality of life. The Holmium laser has a unique microburst effect and the most shallow tissue penetration depth, allowing the operator to clearly identify the plane of the enlarged prostate gland and the surgical envelope, achieving a fine separation and minimal tissue damage. 2. The Holmium laser used in “HoLEP” (Holmium Laser Enucleation of the Prostate) has a water absorption rate of 0.4 mm, and the tip of the laser fiber is 5.0 mm away from the tissue during the surgery, which has no effect on the tissue. If the urethra and bladder are filled with water, the procedure can be performed with ease and without affecting other tissues. 2.0 mm or less of the distance can be used to remove tissue and to stop bleeding by ablating the tissue. This shows that the “HoLEP” (Holmium Laser Prostate Enucleation) treatment method is characterized by low bleeding, rapid post-operative recovery, and greatly shortened hospital stay. 3. Surgery with minimal pain. The “HoLEP” (Holmium Laser Enucleation of the Prostate) treatment removes the junction of the outer and inner glands where there are fewer blood vessels in the prostate tissue, so bleeding and post-operative pain are minimal, thus greatly reducing the frequency of analgesic use. TURP (transurethral resection of the prostate), which uses non-electrolyte fluid instillation, is absorbed by the body and can easily lead to complications of hyponatremia. However, the use of saline, which is equal to the osmotic pressure of blood and tissue fluid, as the irrigation fluid for HoLEP surgical treatment will not cause hyponatremia. The HoLEP surgical treatment uses holmium laser to remove the enlarged prostate tissue and there is almost no residual tissue, so the possibility of recurrence is extremely low. The latest large-scale study in the United States shows that the 10-year recurrence rate of HoLEP is only 1 percent. 6. More high-risk patients get the chance to have surgery. Because of the high surgical safety of HoLEP, patients who were previously considered contraindicated for prostate surgery, such as those of advanced age, high risk, coagulation dysfunction, and those taking anticoagulants, have been given the opportunity to have surgery again, and are able to get rid of the problem of long-term indwelling urinary catheters. 7. Two surgeries, all at once. Some BPH patients are combined with bladder stones. Holmium laser can simultaneously and efficiently perform bladder lithotripsy with less damage to the bladder and avoid frequent intraoperative instrument changes. The Holmium laser and the Nd:, YAG laser can be emitted by the same fiber, which makes the hemostatic effect more effective and rapid. The combination of advanced technology and high-tech equipment will definitely bring faster, more thorough and less painful quality medical services to the majority of prostate hyperplasia patients.